T. Yanagimachi

发表

Prediabetes Exhibits Decreased Disposition Index Correlated with Deterioration of Glycemic Parameters in Nonobese Japanese Subjects: A Cross-Sectional Study from Medical Examination.

M. Haneda, Y. Fujita, J. Honjo, 2017, Metabolic syndrome and related disorders.

Sodium-Glucose Cotransporter 2 Inhibitor and a Low Carbohydrate Diet Affect Gluconeogenesis and Glycogen Content Differently in the Kidney and the Liver of Non-Diabetic Mice

Y. Makino, M. Haneda, Y. Fujita, 2016, PloS one.

学位論文 Sodium-glucose cotransporter 2 inhibitor and a low carbohydrate diet affect gluconeogenesis and glycogen content differently in the kidney and the liver of non-diabetic mice (Sodium-glucose cotransporter 2 ( SGLT 2 )

Y. Makino, Y. Fujita, J. Honjo, 2016 .

Metabolic Changes Induced by Dapagliflozin, an SGLT2 Inhibitor, in Japanese Patients with Type 2 Diabetes Treated by Oral Anti-diabetic Agents: A Randomized, Clinical Trial.

H. Arima, K. Morino, H. Maegawa, 2022, Diabetes research and clinical practice.

Impacts of Diabetes and an SGLT2 Inhibitor on the Glomerular Number and Volume in db/db Mice, as Estimated by Synchrotron Radiation Micro-CT at SPring-8

K. Uesugi, Y. Makino, Y. Saijo, 2018, EBioMedicine.

Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation test

M. Haneda, Y. Fujita, T. Ota, 2019, BMC Endocrine Disorders.

Increment of plasma glucose by exogenous glucagon is associated with present and future renal function in type 2 diabetes:a retrospective study from glucagon stimulation test

M. Haneda, Y. Fujita, T. Ota, 2019, BMC Endocrine Disorders.

Dipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects

Y. Makino, M. Haneda, T. Kieffer, 2016, Molecular metabolism.

Pancreatic glucose-dependent insulinotropic polypeptide (GIP) (1–30) expression is upregulated in diabetes and PEGylated GIP(1–30) can suppress the progression of low-dose-STZ-induced hyperglycaemia in mice

Y. Makino, M. Haneda, T. Kieffer, 2016, Diabetologia.

Receptor-Mediated Bioassay Reflects Dynamic Change of Glucose-Dependent Insulinotropic Polypeptide by Dipeptidyl Peptidase 4 Inhibitor Treatment in Subjects With Type 2 Diabetes

H. Yokoyama, M. Haneda, Y. Fujita, 2020, Frontiers in Endocrinology.

Alternative form of glucose‐dependent insulinotropic polypepide and its physiology

Y. Makino, M. Haneda, Y. Fujita, 2016, Journal of diabetes investigation.

Hypothalamic AMP-Activated Protein Kinase Regulates Biphasic Insulin Secretion from Pancreatic β Cells during Fasting and in Type 2 Diabetes

T. Uzu, H. Maegawa, S. Kume, 2016, EBioMedicine.

Glycaemia and body weight are regulated by sodium-glucose cotransporter 1 (SGLT1) expression via O-GlcNAcylation in the intestine

K. Morino, H. Maegawa, E. Nishi, 2022, Molecular metabolism.

High glucose induces platelet‐derived growth factor‐C via carbohydrate response element‐binding protein in glomerular mesangial cells

Y. Makino, M. Haneda, Y. Fujita, 2016, Physiological reports.

Establishment of novel specific assay for short‐form glucose‐dependent insulinotropic polypeptide and evaluation of its secretion in nondiabetic subjects

H. Yokoyama, M. Haneda, Y. Fujita, 2020, Physiological reports.

Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice

Y. Makino, M. Haneda, T. Kieffer, 2012, Diabetologia.

A Low-Carbohydrate Diet Improves Glucose Metabolism in Lean Insulinopenic Akita Mice Along With Sodium-Glucose Cotransporter 2 Inhibitor

Y. Makino, M. Haneda, Y. Fujita, 2020, Frontiers in Endocrinology.